N. Lowe

发表

Laser Skin Resurfacing: Pre‐ and Posttreatment Guidelines

M. Griffin, N. Lowe, G. Lask, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar.

L. Taylor, N. Lowe, M. Wortzman, 1983, Journal of the American Academy of Dermatology.

Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone.

R. Armstrong, J. Edelstein, N. Lowe, 1991, Journal of the American Academy of Dermatology.

Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences

P. Yamauchi, N. Lowe, P. Yamauchi, 2004, The British journal of dermatology.

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

S. Iyer, P. Yamauchi, N. Lowe, 2002 .

Depletion of cutaneous glutathione and the induction of inflammation by 8-methoxypsoralen plus UVA radiation.

L. Wheeler, N. Lowe, M. Connor, 1986, The Journal of investigative dermatology.

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

M. Naumann, N. Lowe, M. Naumann, 2001, BMJ : British Medical Journal.

Vein imaging laser reduces bruising in bruise-prone botulinum toxin injected patients

N. Lowe, D. Halliday, 2016, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Adverse Effects of Retinoids

E. Hodak, N. Lowe, M. David, 1988, Medical toxicology and adverse drug experience.

Photochemotherapy for mycosis fungoides: a clinical and histological study.

N. Lowe, C. Vickers, D. Cripps, 1979, Archives of dermatology.

Q-switched ruby laser. Further observations on treatment of professional tattoos.

N. Lowe, D. Luftman, D. Sawcer, 1994, The Journal of dermatologic surgery and oncology.

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy

A. Menter, C. Ellis, N. Lowe, 2003, International journal of dermatology.

Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-l-lactic acid for nasolabial folds

N. Lowe, Philippa L Lowe, R. Patnaik, 2011, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Adverse reactions to dermal fillers: A review of European experiences

N. Lowe, T. Clérici, P. André, 2005, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Arterial embolization caused by injection of hyaluronic acid (Restylane)

N. Lowe, Nicholas J. Lowe, 2003, The British journal of dermatology.

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

M. Lebwohl, P. Linsley, H. Ochs, 1999, The Journal of clinical investigation.

Association of HLA-DR4 with vitiligo.

N. Lowe, J. Tiwari, L. Foley, 1983, Journal of the American Academy of Dermatology.

Association of psoriasis with HLA‐DR7

W. Abramovits, N. Lowe, J. Tiwari, 1982, The British journal of dermatology.

Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.

R. Kunkel, K. Simpson, N. Lowe, 1996, Journal of the American Academy of Dermatology.

Carbohydrate metabolism in lichen planus

N. Lowe, A. Cudworth, M. Bullen, 1976, The British journal of dermatology.

Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Palmar Hyperhidrosis: A Double‐Blind, Randomized, Placebo‐Controlled Study

S. Iyer, N. Lowe, G. Lask, 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Current systemic therapies for psoriasis: where are we now?

N. Lowe, P. Yamauchi, T. Kormeili, 2003, Journal of the American Academy of Dermatology.

Effects of acitretin on the liver.

R. Armstrong, J. Callen, H. Roenigk, 1999, Journal of the American Academy of Dermatology.

Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.

N. Lowe, J. Ashley, M. Borok, 1988, Journal of the American Academy of Dermatology.

Cyclosporine as maintenance therapy in patients with severe psoriasis.

D. Margolis, R. Freinkel, E. Bauer, 1997, Journal of the American Academy of Dermatology.

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.

M. Lebwohl, J. Koo, G. Krueger, 2003, Journal of the American Academy of Dermatology.

The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.

P. Elias, G. Krueger, G. Weinstein, 1998, Archives of dermatology.

The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.

R. Stern, C. Ellis, N. Lowe, 1995, Journal of the American Academy of Dermatology.

Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.

J. Leyden, Z. Draelos, N. Lowe, 2001, Cutis.

Tazarotene plus UVB phototherapy in the treatment of psoriasis.

J. Koo, N. Lowe, J. Sefton, 2000, Journal of the American Academy of Dermatology.

The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.

D. M. Brown, T. Rosen, E. Orenberg, 1992, Journal of the American Academy of Dermatology.

Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis

N. Lowe, P. Yamauchi, 2008, International journal of dermatology.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

B. Elewski, J. Leyden, Sewon Kang, 1998, Journal of the American Academy of Dermatology.

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.

N. Konnikov, A. Bucko, N. Levine, 1998, Journal of the American Academy of Dermatology.

Optimizing poly‐l‐lactic acid use

N. Lowe, 2008, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

The place of botulinum toxin type A in the treatment of focal hyperhidrosis: reply from authors

N. Lowe, 2005, The British journal of dermatology.

Infmorbital Pigmented Skin: Preliminary Observations of Laser Therapy

N. Lowe, C. Boxrud, N. Shorr, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

CTLA 4 Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

M. Lebwohl, P. Linsley, H. Ochs, 1999 .

Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.

H. Schaefer, N. Lowe, R. Ashton, 1984, Journal of the American Academy of Dermatology.

PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.

N. Lowe, T. Bourget, L. Moy, 1986, Journal of the American Academy of Dermatology.

Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.

N. Lowe, J. Breeding, 1981, Archives of dermatology.

Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema.

R. Fitzpatrick, N. Lowe, K. Behr, 1991, The Journal of dermatologic surgery and oncology.

Scrotal squamous cell carcinoma in a psoriatic patient treated with coal tar.

N. Lowe, L. Moy, M. Chalet, 1986, Journal of the American Academy of Dermatology.

Coexistent psoriasis and lupus erythematosus: Successful therapy with etretinate

N. Lowe, M. David, D. Saperia, 1989 .

Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.

B. Goffe, C. Guzzo, G. Lazarus, 1996, Journal of the American Academy of Dermatology.

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.

J. Waldstreicher, D. Thiboutot, L. Drake, 1999, Journal of the American Academy of Dermatology.

Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.

N. Lowe, R. Kaplan, D. Russell, 1983, Journal of the American Academy of Dermatology.

Ultraviolet light and epidermal polyamines.

N. Lowe, 1981, The Journal of investigative dermatology.

Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light.

A. Verma, N. Lowe, R. Boutwell, 1979, Cancer research.

Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction.

N. Lowe, J. Breeding, M. Connor, 1983, Cancer research.

Inhibition of ultraviolet-B epidermal ornithine decarboxylase induction and skin carcinogenesis in hairless mice by topical indomethacin and triamcinolone acetonide.

N. Lowe, J. Breeding, M. Connor, 1982, Cancer research.

Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens.

N. Sidell, N. Lowe, M. Connor, 1990, The Journal of investigative dermatology.

The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.

N. Lowe, P. Yamauchi, Vivian Gindi, 2004, Dermatologic clinics.

Use of topical metronidazole in moderate to severe rosacea

N. Lowe, 2003, Advances in therapy.

Editorial

D. Goldberg, N. Lowe, G. Lask, 2002 .

An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses.

N. Lowe, 2006, Dermatologic clinics.

Inductionof Mouse EpidermalOrnithineDecarboxylaseActivityand DNA Synthesisby UltravioletLight1

A. Verma, N. Lowe, R. Boutwell, 1979 .

Essential fatty acid deficient hairless mouse: the effects of topical agents on the epidermis

N. Lowe, 1977, The British journal of dermatology.

Evaluation of sunscreen protection by measurement of epidermal DNA synthesis.

N. Lowe, J. Breeding, 1980, The Journal of investigative dermatology.

Comparisons among Botulinum Toxins: An Evidence-Based Review

A. Klein, A. Carruthers, N. Lowe, 2008, Plastic and reconstructive surgery.

Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.

R. Halder, N. Lowe, M. Borok, 1990, Journal of the American Academy of Dermatology.

Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids.

N. Lowe, R. Ashton, M. Connor, 1984, The Journal of investigative dermatology.

Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque‐type psoriasis

S. Feldman, J. Weiss, N. Lowe, 2005, The Journal of dermatological treatment.

Generalized pustular psoriasis precipitated by lithium carbonate.

N. Lowe, H. Ridgway, 1978, Archives of dermatology.

Epidermal ornithine decarboxylase, polyamines, cell proliferation, and tumor promotion.

N. Lowe, 1980, Archives of dermatology.

Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.

Sewon Kang, A. Menter, C. Langman, 2004, Journal of the American Academy of Dermatology.

A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis

J. Stanley, N. Lowe, M. Hayton, 2003, The British journal of dermatology.

Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis on Behalf of the Multi-specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis

Kevin Grimes, John Hornberger, Dee Anna Glaser, 2022 .

Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.

M. Naumann, H. Hamm, N. Lowe, 2003, Archives of dermatology.

Botulinum Toxin Type A in the Treatment of Bilateral Primary Axillary Hyperhidrosis: Efficacy and Duration With Repeated Treatments

N. Lowe, P. L. Lowe, Suzanne Cerdan-Sanz, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Photo(chemo)therapy: general principles.

N. Lowe, V. Chizhevsky, V. Chizhevsky, 1997, Clinics in dermatology.

Induction of Ornithine Decarboxylase Activity and DMA Synthesis in Hairless Mouse Epidermis by Retinoids1

N. Lowe, M. Connor, 2006 .

Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.

N. Lowe, M. Connor, 1983, Cancer research.

Psoriasiform dermatosis in a rhesus monkey. Epidermal labeling indexes, polyamines, and histopathologic findings.

N. Lowe, J. Breeding, D. Russell, 1982, Archives of dermatology.

Cutaneous polyamines in psoriasis

N. Lowe, J. Breeding, D. Russell, 1982, The British journal of dermatology.

Adverse reactions to dermal fillers: review.

N. Lowe, Nicholas J Lowe, C Anne Maxwell, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Photoreactions with a fluoroquinolone antimicrobial: Evening versus morning dosing

R. Stern, B. Roniker, E. Swabb, 1994, Clinical pharmacology and therapeutics.

Sunscreens : development, evaluation, and regulatory aspects

N. Lowe, N. Shaath, 1990 .

Actinic reticuloid in a black man: successful therapy with azathioprine.

N. Lowe, H. Sofen, D. Weingarten, 1987, Journal of American Academy of Dermatology.

Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review

A. Ghanem, N. Lowe, M. Pissaridou, 2020, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.

N. Lowe, L. Kakita, 1998, Clinical therapeutics.

Sunscreens. Update and review.

R. Moy, N. Lowe, D. Luftman, 1991, The Journal of dermatologic surgery and oncology.

New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay.

N. Lowe, M. Wortzman, J. Breeding, 1982, Archives of dermatology.

Sunscreens and phototesting.

N. Lowe, M. Wortzman, D. Weingarten, 1988, Clinics in dermatology.

Sunscreens and the prevention of skin aging.

N. Lowe, 1990, The Journal of dermatologic surgery and oncology.

Ultraviolet radiation-induced connective tissue changes in the skin of hairless mice.

J. Uitto, J. Clark, A. Oikarinen, 1984, The Journal of investigative dermatology.

Low doses of repetitive ultraviolet A induce morphologic changes in human skin.

N. Lowe, D. Luftman, D. Meyers, 1995, The Journal of investigative dermatology.

Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.

J. Leyden, J. Ortonne, S. Kang, 2001, Archives of dermatology.

Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects.

N. Lowe, J. Sefton, T. Bourget, 1987, Journal of the American Academy of Dermatology.

Cutaneous phototoxicity reactions

N. Lowe, 1986, The British journal of dermatology.

Models in dermatology

Howard I. Maibach, H. Maibach, N. Lowe, 1987 .

Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.

B. Berman, J. Leyden, M. Stiller, 1992, Journal of the American Academy of Dermatology.

Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.

L. Drake, J. Jorizzo, C. Ellis, 1991, Cutis.

One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.

B. Elewski, B. Reyes, A. Lucky, 1997, Journal of the American Academy of Dermatology.

Ciclopirox gel for seborrheic dermatitis of the scalp

A. Menter, R. Aly, N. Lowe, 2003, International journal of dermatology.

Percutaneous absorption in experimental epidermal disease

N. Lowe, A. Solomon, A. E. Solomon, 1979, The British journal of dermatology.

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients.

P. Grimes, N. Lowe, S. Pincus, 1998, Clinical therapeutics.

Ciclopirox gel in the treatment of patients with interdigital tinea pedis

A. Menter, N. Levine, J. Taylor, 2003, International journal of dermatology.

Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.

N. Lowe, T. Kingston, L. Matt, 1987, Archives of dermatology.

Systemic retinoid therapy for psoriasis.

N. Lowe, L. Matt, V. Lazarus, 1988, Journal of the American Academy of Dermatology.

Etretinate. Appropriate use in severe psoriasis.

J. Voorhees, H. Roenigk, N. Lowe, 1988, Archives of dermatology.

Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy.

N. Lowe, J. Ashley, M. Borok, 1988, Archives of dermatology.

Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase.

N. Lowe, J. Breeding, R. Kaplan, 1982, Journal of the American Academy of Dermatology.

Minimally Invasive Treatments and Procedures for Ageing Skin

N. Lowe, 2010 .

Retinoids: A Clinician's Guide

R. Marks, N. Lowe, 1997 .

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.

J. Imperato-McGinley, K. Kaufman, E. Olsen, 1999, Journal of the American Academy of Dermatology.

Coexistence of lichen planus and systemic lupus erythematosus.

W. Abramovits, N. Lowe, A. Ahmed, 1982, Journal of the American Academy of Dermatology.

Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream.

N. Lowe, M. David, 1989, Journal of the American Academy of Dermatology.

A report of two patients with lichen aureus.

W. Abramovits, N. Lowe, J. Landau, 1980, Archives of dermatology.

Retinoid therapy for psoriasis.

N. Lowe, P. Yamauchi, Dalia Rizk, 2004, Dermatologic clinics.

Systemic retinoids for psoriasis.

N. Lowe, J. Wieder, 1995, Dermatologic clinics.

Newer retinoids for psoriasis--early clinical studies.

N. Lowe, L. Matt, V. Lazarus, 1989, Pharmacology & therapeutics.

New retinoids for dermatologic diseases. Uses and toxicity.

N. Lowe, M. David, Nicholas J. Lowe, 1988, Dermatologic clinics.

A randomized trial of etanercept as monotherapy for psoriasis.

A. Gottlieb, Sewon Kang, K. Gordon, 2003, Archives of dermatology.

Pityriasis rubra pilaris. Further observations of systemic retinoid therapy.

N. Lowe, M. Borok, M. Borok, 1990, Journal of the American Academy of Dermatology.

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.

G. Krueger, G. Weinstein, M. Duvic, 1997, Journal of the American Academy of Dermatology.

Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study.

R. Stern, R. Armstrong, J. Parrish, 1986, Journal of the American Academy of Dermatology.

Anthralin: historical and current perspectives.

P. André, N. Lowe, R. Ashton, 1983, Journal of the American Academy of Dermatology.

Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.

N. Lowe, P. Yamauchi, Vivian Gindi, 2006, Journal of the American Academy of Dermatology.

Phototherapy and dithranol treatment of psoriasis.

N. Lowe, 1987, British medical journal.

HL‐A antigens in lichen planus

N. Lowe, A. Cudworth, J. Woodrow, 1976, The British journal of dermatology.

Proliferative epidermis of essential fatty acid deficient mice has reduced cyclic AMP content

J. Voorhees, N. Lowe, E. Duell, 1979, The British journal of dermatology.

Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.

N. Lowe, P. Yamauchi, Vivian Gindi, 2006, Journal of the American Academy of Dermatology.

Therapy of Scalp Psoriasis

N. Lowe, 1984 .

The pharmacological variability of crude coal tar

N. Lowe, M. Wortzman, J. Breeding, 1982, The British journal of dermatology.

Pityriasis rubra pilaris and cyclosporine.

N. Lowe, A. Rosenbach, 1993, Archives of dermatology.

Injectable Hyaluronic Acid Implant for Malar and Mental Enhancement

R. Grover, N. Lowe, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Evidence-based recommendations for the treatment of primary axillary and palmar hyperhidrosis

M. Naumann, N. Lowe, D. Glaser, 2004 .

Photodynamic Therapy: A Clinical Consensus Guide

M. Gold, D. Ozog, G. Martin, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

A. Oseroff, A. Menter, D. Murrell, 2009, International journal of dermatology.

Topical photodynamic therapy in clinical dermatology

P. Yamauchi, N. Lowe, N J Lowe, 2004, The British journal of dermatology.

Eruptive squamous cell carcinomata following psoralen‐UVA phototoxicity

N. Lowe, M. Chalet, J. Kahn, 1986, Clinical and experimental dermatology.

Skin Resurfacing with the Ultrapulse Carbon Dioxide Laser: Observations on 100 Patients

M. Griffin, N. Lowe, G. Lask, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Hyaluronic acid skin fillers: adverse reactions and skin testing.

N. Lowe, N J Lowe, C A Maxwell, 2001, Journal of the American Academy of Dermatology.

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

A. Lucky, R. Pariser, D. Pariser, 2003, Journal of the American Academy of Dermatology.

Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.

A. Gottlieb, J. Leyden, T. Phillips, 2002, Archives of dermatology.

Laser Skin Resurfacing with the Silk Touch Flashscanner for Facial Rhytides

N. Lowe, G. Lask, D. Gormley, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis.

F. Urbach, N. Lowe, D. Weingarten, 1987, Journal of the American Academy of Dermatology.

Photochemotherapy for psoriasis remission times. Psoralens and UV‐A and combined photochemotherapy with anthralin

N. Lowe, D. Cripps, 1979, Clinical and experimental dermatology.

Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.

R. Moy, N. Lowe, T. Kingston, 1985, Archives of dermatology.

Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.

Susan C. Taylor, L. Baumann, A. Menter, 2003, Cutis.

Laser Hair Removal

N. Lowe, G. Lask, Donna Lee, 2001, Principles and Choice of Laser Treatment in Dermatology.

Staphylococcal scalded skin syndrome in an adult with Hodgkin's disease.

N. Lowe, H. Ridgway, 1979, Archives of dermatology.

Radiofrequency Devices Including Fractional Radiofrequency

A. Ghanem, Ileana Afroditi Kleidona, N. Lowe, 2020, Practical Introduction to Laser Dermatology.

A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.

Susan C. Taylor, L. Baumann, A. Menter, 2005, Journal of drugs in dermatology : JDD.

Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double‐blind, randomized, parallel‐group study

Sewon Kang, Y. Poulin, Y. Tse, 2004 .

A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.

J. Carruthers, M. Menter, P. Walker, 2002, Journal of the American Academy of Dermatology.

Four methods of evaluation of facial erythema and pigment treated with intense pulsed light or cream

R. Barlow, N. Lowe, DAVID W.S. Harris, 2012, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Pityriasis rubra pilaris: Etretinate shortens duration of disease

N. Lowe, P. Tabibian, 1993 .

Laser Resurfacing in Pigmented Skin

M. Griffin, N. Lowe, G. Lask, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser.

N. Lowe, D. Sawcer, M. Chalet, 1993, Journal of the American Academy of Dermatology.

Effects of topical prostaglandin E analogue on normal hairless mouse epidermal DNA synthesis.

N. Lowe, R. Stoughton, 1977, The Journal of investigative dermatology.

A comparative study of the induction of epidermal hyperplasia by natural and synthetic retinoids.

N. Lowe, R. Ashton, M. Connor, 1986, The Journal of pharmacology and experimental therapeutics.

Topical drug effects on normal and proliferating epidermal cell models.

G. Weinstein, J. Mccullough, N. Lowe, 1981, Archives of dermatology.

Essential fatty acid deficient hairless mouse: a model of chronic epidermal hyperproliferation

N. Lowe, R. Stoughton, RICHARD B. STOUGHTON, 1977, The British journal of dermatology.

Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.

J. Kowalski, N. Lowe, P. Lai, 2007, Journal of the American Academy of Dermatology.

CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study.

A. Gottlieb, T. Casale, H. Ochs, 2003, Journal of the American Academy of Dermatology.

The use of photodynamic therapy in dermatology: results of a consensus conference.

J. Carruthers, R. Anderson, D. Rigel, 2006, Journal of drugs in dermatology : JDD.

The place of botulinum toxin type A in the treatment of focal hyperhidrosis

M. Naumann, P. Jaen, I. Bodokh, 2004 .

Fractional radiofrequency in the treatment of skin aging: an evidence-based treatment protocol

A. Ghanem, S. Myers, D. Karypidis, 2019, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures.

N. Lowe, P. Yamauchi, R. Ram, 2007, Cutis.

Microwave delivery system for lower leg telangiectasia

N. Lowe, Bojidar Grozdev, Donna Moore, 2000, Journal of cutaneous laser therapy.

Extensive spinal hyperostosis in a patient receiving isotretinoin—progression after 4 years of etretinate therapy

W. Griffiths, N. Lowe, C. Archer, 1989, Clinical and experimental dermatology.

Botulinum Toxins for Facial Lines: A Concise Review

N. Lowe, Philippa L Lowe, 2012, Dermatology and Therapy.

Psoriasiform dermatosis in a rhesus monkey.

N. Lowe, J. Breeding, C. Kean, 1981, The Journal of investigative dermatology.

Electron‐beam treatment of scleromyxoedema

N. Lowe, R. Hunter, C. Vickers, 1982, The British journal of dermatology.

Light‐emitting diode 415 nm in the treatment of inflammatory acne: An open‐label, multicentric, pilot investigation

R. Moy, J. Tremblay, N. Lowe, 2006, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Lasers and adjunctive treatments for facial scars: a review.

N. Lowe, H. R. Lee, D. Sawcer, 1999, Journal of Cutaneous Laser Therapy.

Scar revision using laser: review of the literature and an appraisal

N. Lowe, D. Sawcer, H.-R. Lee, 1998 .

Controversies in Cutaneous Surgery Laser

N. Lowe, 1999 .

Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience.

N. Lowe, Nicholas J Lowe, K. Butterwick, 2009, Journal of the American Academy of Dermatology.

Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.

Rod J. Rohrich, G. Monheit, L. Baumann, 2011, Aesthetic surgery journal.

A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.

Rod J. Rohrich, G. Monheit, L. Baumann, 2010, Journal of the American Academy of Dermatology.

Subject Global Evaluation and Subject Satisfaction Using Injectable Poly-l-Lactic Acid versus Human Collagen for the Correction of Nasolabial Fold Wrinkles

Rod J. Rohrich, G. Monheit, L. Baumann, 2011, Plastic and reconstructive surgery.

On the need for greater regulation of medical devices.

N. Lowe, 2000, Journal of cutaneous laser therapy.

RETINOIDS AND MALIGNANCY

W. Cunliffe, W. Griffiths, J. Rhodes, 1987, The Lancet.

Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003 .

Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003, Journal of cutaneous medicine and surgery.

Sunscreen Evaluation by Mouse Spectrophotometric and Human Assays

N. Lowe, J. Breeding, 1986 .

Animal assays for anti‐psoriatic., retinoid and sunprotective agents

N. Lowe, R. Ashton, M. Wortzman, 1984, British Journal of Dermatology.

THE INDUCTION OF ERYTHEMA, EDEMA, and THE POLY AMINE SYNTHESIS ENZYMES ORNITHINE DECARBOXYLASE and S‐ADENOSYL‐L‐METHIONINE DECARBOXYLASE IN HAIRLESS MOUSE SKIN BY PSORALENS and LONGWAVE ULTRAVIOLET LIGHT

N. Lowe, M. Connor, 1984, Photochemistry and Photobiology.

Retinoic acid modulation of ultraviolet light-induced epidermal ornithine decarboxylase activity.

N. Lowe, J. Breeding, Nicholas J. Lowe, 1982, The Journal of investigative dermatology.

Antiinflammatory drug effects on ultraviolet light-induced epidermal ornithine decarboxylase and DNA synthesis.

N. Lowe, J. Breeding, 1980, Journal of Investigative Dermatology.

Epidermal pyridoxal 5'-phosphate depletion, inhibition of DNA synthesis, and inhibition of the expression of ornithine decarboxylase activity by the vitamin B-6 antagonist 4'-deoxypyridoxine.

N. Lowe, M. Connor, 1983, The Journal of investigative dermatology.

Epidermal polyamine profiles after multiple exposures to ultraviolet radiation.

N. Lowe, J. Breeding, M. Connor, 1983, Carcinogenesis.

Etretinate for retinoid-responsive dermatoses: further observations of long-term therapy

K. Simpson, N. Lowe, A. Rosenbach, 1993 .

Mini‐Slit Graft Hair Transplantation Using the Ultrapulse Carbon Dioxide Laser Handpiece

N. Lowe, G. Lask, C. Ho, 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.

M. Lebwohl, J. Callen, T. Phillips, 1998, Journal of the American Academy of Dermatology.

Double‐Blind, Randomized, Placebo‐Controlled, Dose‐Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's Feet

B. Ascher, M. Heckmann, N. Lowe, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Botulinum Toxin Type A for Facial Rejuvenation: United States and United Kingdom Perspectives

N. Lowe, 1998, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Cosmetic uses of botulinum toxins for lower aspects of the face and neck.

N. Lowe, P. Yamauchi, 2004, Clinics in dermatology.

Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.

N. Lowe, G. Lask, P. Yamauchi, 2002, Journal of the American Academy of Dermatology.

Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique.

N. Lowe, H. Harper, H. Harper, 1996, Journal of the American Academy of Dermatology.

Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial Skin

A. Gottlieb, M. Lebwohl, Sewon Kang, 2005, American journal of clinical dermatology.

Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing

N. Lowe, G. Lask, P. Yamauchi, 2004, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.

N. Lowe, P. Yamauchi, 2004, Clinics in dermatology.

Randomized, Placebo-Controlled Phase 1/2 Study to Determine the Appropriate ATX-101 Concentration for Reduction of Submental Fat

L. Spelman, N. Lowe, G. Goodman, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

James T. Elder, A. Gottlieb, M. Lebwohl, 2000, Journal of the American Academy of Dermatology.

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.

J. Strauss, J. Leyden, L. Drake, 2001, Journal of the American Academy of Dermatology.

Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study.

N. Lowe, Philippa L Lowe, R. Patnaik, 2006, Journal of the American Academy of Dermatology.

Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines

N. Lowe, Philippa L Lowe, R. Patnaik, 2010, Journal of Cosmetic & Laser Therapy.

Aesthetic Uses of Botulinum Toxins

N. Lowe, 2016 .

Botulinum Toxin Type B: pH Change Reduces Injection Pain, Retains Efficacy

N. Lowe, Philippa L Lowe, Philippa L. Lowe, 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Overview of botulinum neurotoxins

N. Lowe, 2007, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Facial aesthetics: Achieving the natural, relaxed look

S. Cox, A. Carruthers, T. Flynn, 2007, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

A Comparison of Two Botulinum Type A Toxin Preparations for the Treatment of Glabellar Lines: Double‐Blind, Randomized, Pilot Study

N. Lowe, Philippa L Lowe, R. Patnaik, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing

N. Lowe, G. Lask, P. Yamauchi, 2002, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Peutz-Jeghers syndrome with pigmented oral papillomas.

N. Lowe, 1975, Archives of dermatology.

Pilot study to determine the efficacy of ALA‐PDT photorejuvenation for the treatment of facial ageing

N. Lowe, Nicholas J Lowe, Philippa Lowe, 2005, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Flash lamp-pumped dye laser treatment of telangiectasia.

R. Fitzpatrick, M. Goldman, N. Lowe, 1993, The Journal of Dermatologic Surgery and Oncology.

Flashlamp-pumped pulsed dye laser treatment of port-wine stains.

M P Goldman, R. Fitzpatrick, R E Fitzpatrick, 1994, The Journal of dermatologic surgery and oncology.

Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial.

L. Millikan, N. Lowe, T. Henderson, 1989, Cutis.

Courses Cutaneous surgery and laser therapyComplications of laser skin resurfacing

N. Lowe, 1998 .

Laser and novel light source treatments for psoriasis

P. Yamauchi, N. Lowe, Joshua A. Tournas, 2004, Lasers in surgery and medicine.

Infraorbital pigmented skin. Preliminary observations of laser therapy

N. Lowe, C. Boxrud, N. Shorr, 1996 .

A Phase IIa Open‐Label Dose‐Escalation Pilot Study Using Allogeneic Human Dermal Fibroblasts for Nasolabial Folds

N. Lowe, Philippa L Lowe, J. St Clair Roberts, 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial

M. Naumann, H. Hamm, N. Lowe, 2002, The British journal of dermatology.

Topical retinoids: in vivo predictive assays.

N. Lowe, 1986, Journal of the American Academy of Dermatology.

13‐cis‐retinoic acid for dyskeratinizing diseases—clinicopathological responses

N. Lowe, R. Ashton, M. Chalet, 1984, Clinical and experimental dermatology.

Psoriasis: In vivo models for topical drug evaluation

N. Lowe, 1988 .

Anti‐inflammatory properties of a prostaglandin antagonist, a corticosteroid and indomethacin in experimental contact dermatitis

N. Lowe, R. Stoughton, Frank Virgadamo, 1977, The British journal of dermatology.

Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments.

N. Lowe, P. Yamauchi, R. Ram, 2007, Cutis.

Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light.

L. Wheeler, N. Lowe, M. Saperstein, 1981, The Journal of investigative dermatology.

Pharmacokinetics of topically applied radiolabeled retinoids in hairless mouse epidermis and dermis after single applications.

N. Lowe, M. Connor, M. L. Lindae, 1985, The Journal of investigative dermatology.

Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device.

R. Halder, N. Lowe, M. David, 1989, Journal of the American Academy of Dermatology.

Factors influencing anthralin irritancy

N. Lowe, T. Kingston, 1986 .

Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.

N. Lowe, P. Yamauchi, 2006, Journal of the American Academy of Dermatology.

Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

J. Strauss, J. Leyden, L. Drake, 2001, Journal of the American Academy of Dermatology.

Retinoid Stimulation of Epidermal Cell Growth in vivo

N. Lowe, M. Connor, 1985 .

Visual and cutaneous toxicity which occurs during N‐(4‐hydroxyphenyl) retinamide therapy for psoriasis

J. Winston, N. Lowe, T. Kingston, 1986, Clinical and experimental dermatology.

Practical Psoriasis Therapy

N. Lowe, 1992 .

Intradermal fluorouracil and epinephrine injectable gel for treatment of psoriatic plaques.

E. Orenberg, A. Korey, N. Lowe, 1995, Archives of dermatology.

A comparison of the efficacy and safety of the combination mometasone furoate 0.1 %/salicylic acid 5% ointment with each of its components in psoriasis

N. Lowe, L. Swinyer, H. Katz, 1998 .

The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin.

N. Lowe, C. Ehmann, B. Patel, 1987, Journal of the American Academy of Dermatology.

Treatment of severe psoriasis with intravenous somatostatin

N. Lowe, T. Kingston, L. Matt, 1989 .

Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double‐blind, randomized study

Z. Draelos, A. Menter, E. Tanghetti, 2006, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis

J. Nedelman, K. Simpson, A. Karara, 1995, Journal of clinical pharmacology.

UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines.

N. Lowe, J. Swinehart, 1991, Journal of the American Academy of Dermatology.

Erythema multiforme‐like eruptions associated with etretinate therapy

N. Lowe, M. David, M. Sandbank, 1989, Clinical and experimental dermatology.

Progress in Diseases of the Skin

N. Lowe, 1985 .

Contribution of topical tar oil to ultraviolet B phototherapy for psoriasis.

N. Lowe, 1986, Journal of the American Academy of Dermatology.

Psoriasis ambulatory treatment centers: United States experience.

N. Lowe, P. Lowe, E. Wasiowich, 1992, Dermatology nursing.

Volume restoration of hands with polycaprolactone by cannula delivery; a prospective single center consecutive case series evaluation

A. Ghanem, N. Lowe, 2020, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Linoleic acid effects on epidermal DNA synthesis and cutaneous prostaglandin levels in essential fatty acid deficiency.

N. Lowe, P. DeQUOY, 1978, The Journal of investigative dermatology.

TRENDS IN TOPICAL PSORIASIS THERAPY

K. Simpson, N. Lowe, 1994, International journal of dermatology.

Phototherapy units: comparison of fluorescent ultraviolet B and ultraviolet A units with a high-pressure mercury system.

N. Lowe, B Chue, M Borok, 1988, Journal of the American Academy of Dermatology.

Psoriasis therapy: a current perspective.

N. Lowe, 1983, Western Journal of Medicine.

Percutaneous absorption in experimental epidermal proliferation.

N. Lowe, A. Solomon, A. E. Solomon, 1978, Archives of dermatology.

Physician's guide to sunscreens

N. Lowe, 1991 .

Textbook of Facial Rejuvenation : The Art of Minimally Invasive Combination Therapy

N. Lowe, 2002 .

The Rhino Mouse: Retinoid Effects on a Model of Keratin Accumulation

N. Lowe, R. Ashton, 1986 .

Cosmetic therapy: glabellar and forehead area

N. Lowe, 2004 .

U.S. experience of immunomodulators in the treatment of psoriasis: reply from authors

P. Yamauchi, N. Lowe, 2005 .

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy: reply from author

N. Lowe, 2002, British Journal of Dermatology.

Woronoff's rings with PUVA therapy.

N. Lowe, F. Bures, 1978, Archives of Dermatology.

U.v. wavelength dependence for the induction of ornithine decarboxylase activity in hairless mouse epidermis.

N. Lowe, M. Connor, A. R. Young, 1986, Carcinogenesis.

Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics.

B. Goffe, N. Lowe, C. Cole, 2021, Current problems in dermatology.

all‐trans‐Retinoic acid inhibits the appearance of two phorbol ester‐induced ornithine decarboxylase mRNAs in mouse epidermis

J. de Vellis, N. Lowe, D. Weingarten, 1986, FEBS letters.

Comparisons among Botulinum Toxins: An Evidence-Based Review

A. Klein, A. Carruthers, N. Lowe, 2008, Plastic and reconstructive surgery.

Recognition, diagnosis, and treatment of primary focal hyperhidrosis.

J. Hornberger, M. Naumann, Kevin Grimes, 2004, Journal of the American Academy of Dermatology.

Botulinum Toxin Type A in the Treatment of Bilateral Primary Axillary Hyperhidrosis: Efficacy and Duration With Repeated Treatments

N. Lowe, Suzanne Cerdan-Sanz, Phillipa L. Lowe, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

International Experts Roundtable Proceedings Supplement

N. Lowe, 2007 .

A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.

F. Kerdel, J. Bernhard, J. Weiss, 1991, Journal of American Academy of Dermatology.